As a result, the ETF reached a new 8-month low. 2% Top Ten Holdings. Thu, Nov 9, 1:16 PM ET, Market News Video. Single Cell Genomics Workflow Automation Cell Analytics Lab Equipment Spatial Genomics Lab Equipment. 90 in this past 52. XBI: SPDR® S&P Biotech ETF: 1. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. 00. Quote. $6. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 36% of total assets under management. In contrast, most. As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. 26% rating in the component of Value. A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. If Moderna's share price. The current portfolio value is calculated to be $6. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. Only one of these, AbbVie, is a. 09%: Canada: 1. 94 per share, with $121. Both FBT and XBI are ETFs. Performance and Risk The ETF has lost about -3. It is gross of any fee waivers or expense reimbursements. XBI touched $73. XBI vs BBH. Warren Buffett is known for holding onto his S&P 500 stocks forever. . SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. Looking at the chart above, XBI's low point in its 52 week range is $63. DLTR. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. But that definitely wasn't the case recently. The firm has a market cap of $5. TG Therapeutics Inc TGTX:US. 71% of total assets under management. Further, the fund owns $6. Investo S&P Biotech Sel Industry ETF IE. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Top 10 Holdings. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. AU. 35%). SPDR S&P Biotech ETF Stock Up 1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. It can be found in the fund’s most recent prospectus. 64 per share, with $174. With XBI trading at a recent price near $131. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. As of Oct 31 2023. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 42 billion worth of net assets. Health Care Fund Highlights: 137 Total Holdings $5. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Free ratings, analyses, holdings, benchmarks, quotes, and news. Share your ideas and get valuable insights from the community of like minded traders and investorsAlaunos Therapeutics, Inc. , Biogen Inc. Holdings. Below is the comparison between XBI and XLV. 1 Day NAV Change as of Nov 09, 2023. com. S. ("Boron One" or the. 70% so far this year and is down about -16. by Morningstar Manager Research. 5. This major support zone runs from $101. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. 79 as the 52 week high point — that compares with a last trade of $126. 83%: Other: 0. Below is the comparison between LABU and XBI. The top holding in XBI receives just a 1. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Both BBC and XBI are ETFs. News & World Report, XBI. 42 billion worth of. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. London. 2015. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. News & World Report, XBI enjoys volume of 20. Better trading starts here. View Holdings As of 09/30/2023. 81% of the total fund's. 96%, and is down about -5. 0. 79 as the 52 week high point — that compares with a last trade of $133. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. The beaten-down prices offer a solid buying opportunity for investors. Holdings; Performance; Risk; Performance Overview-12. Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Year-to-date, the SPDR S&P Biotech ETF has lost about -15. 46% YTD Daily Total Return ETF Summary. 66%. One of the ideas making the rounds on Wall Street right now (I’ve seen it commented on in a number of places) is buying XBI, the SPDR S&P Biotech ETF, at this time of year, for a spring rally. XBI is an equal-weight passively-managed biotech ETF while ARKG is an actively-managed genomics ETF. 35% for XBI, but SBIO yields 2. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). XBI holdings. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. 91 Billion . View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. 53 (+3. 04 per unit, that means that analysts see 73. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 12% in the. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. The vast majority of XBI holdings have less. Carnage in small and micro-cap biotech stocks took XBI from $111. In XBI, the top five holdings together represent only 9. by Sweta Killa Published on September 18,2023. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. XBI has traded between $73. A few losers won't cause XBI to crash. View Holdings As of 08/31/2023. Skip to main content. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. The ETF has lost about -12. 2. XBI, HZNP, BIIB, VCYT: ETF Outflow Alert. VHT has a lower expense ratio than XBI (0. 08 per unit, that means that analysts see 59. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. XBI holdings. Learn everything about iShares Biotechnology ETF (IBB). 89%. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. iShares Biotechnology ETF ETF holdings by MarketWatch. Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. 5% position, and no other holding accounts for more than 1. 0. Implied XBI Analyst Target Price: $135. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. 60 as the 52 week high point — that compares with a last trade of $77. XBI vs ARKG. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. ETFs - IBB, PBE, XBI. The gross expense ratio is the fund’s total annual operating expenses ratio. Jun 8, 2022 10:51AM EDT. $5. The sale of ETFs is subject to an activity assessment fee (from $0. Mirati. Export data to Excel for your own analysis. Looking at the chart above, XBI's low point in its 52 week range is $62. 51. The weighted harmonic average of closing market price divided by. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. XBI is an equal-weighted ETF that follows the S&P Biotechnology Select Industry Index. The weighted harmonic average of closing market price divided by. The index and exchange-traded fund ETF are rebalanced four times a year. 81 and $97. ARKG vs XBI Fund Comparison . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. As I understand it, this attribute was added to the methodology to protect against having too. Discover historical prices for XBI stock on Yahoo Finance. To make the peptide traceable, it was radiolabeled with the long. Performance. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI. 39. 47 million over the past three months. 03 per $1,000 of principal). XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. 67% Symbol Company Name Industry Percent of Assets MRTX Mirati Therapeutics Inc Biotechnology 2. With XBI trading at a recent price near $122. 20. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. The iShares Core S&P 500 ETF Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Growth of Hypothetical $10,000. XBI has lost 27. 35%. 45% and is down about -9. Shares Held Weight In Fund. 81 and $97. XBI is an almost pure play on the biotechnology sector. 51. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. Additionally. XBI holdings. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Major Holdings. It has a total of 153 holdings. 40. Market Capitalization. Below is the comparison between ARKG and XBI. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. 86% so far this year and is down about -32. 4% of the stocks in our database. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. SBIO holds 79 companies vs. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. XBI currently has 133 holdings. SPDR® S&P Biotech ETF XBI: NYSE Arca . 78% of XBI's total assets under management. , and Amgen Inc. In trading on Monday the SPDR S&P Biotech ETF is outperforming other ETFs up about 2% on the day. Meanwhile, XBI equal weights its holdings. $0. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. Lucy Brewster | Nov 10, 2023. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. 9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Meanwhile, XBI equal weights its holdings. All 33 ARKK ETF Holdings. All 142 XBI Holdings. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. 57 billion. Of course the mega caps are less volatile in general for any sector. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 38%. The Composition of the XBI is the Key. Components of. XBI has traded between $62. VHT has a higher 5-year return than XBI (7. Also I like this style of etf from power shares because the holdings are less weighted in the top two powerhouses (Amgen and Gilead for PJP) than "traditional" ETF's. XBI ETF's holdings offer significant diversification. The split for XBI took place on September 11, 2015. Expense ratio and liquidity are average for the group. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. 1%). Overview. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. 58%). IMVT. View the XBI funds market news. Discover historical prices for XBI stock on Yahoo Finance. NAV as of Nov 16, 2023. While I love Cathie Wood, I just don't see how she can keep this up. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. 35%. In addition to holding 155 positions, its top 10 holdings make up just 14. XBI is suitable for investors seeking to. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. " The 12-month stock price forecast is $22. Performance and Risk. The ETF has lost about -12. 0. Stocks. Performance and Risk The ETF has lost about -29. In that past 52-week period, it has traded between $62. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . Below is the comparison between IBB and XBI. Monday's ETF Movers: XBI, QCLN. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 99%. 60 as the 52 week high point — that compares with a last trade of $69. $0. Performance and Risk The ETF has lost about -9. Performance and Risk. 2% weight, and there are 133 holdings in total in the fund (Figure 1). Performance and Risk. XBI has a beta of 0. 60 as the 52 week high point — that compares with a last trade of $77. Veeva Systems. 41% so far this year and in the past one year (as of 01/23/2023), respectively. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. Below is the comparison between VHT and XBI. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. According to data from U. S. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI has a lower 5-year return than XLV (-5. Stock Analysis Chart Headlines Holdings Ownership Ratings. Performance and Risk. 06 a share on Wednesday which marked its lowest level dating back to June 30 of 2022. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Below is the comparison between BBH and XBI. 3. 8% of its total assets under management. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Morningstar Medalist Rating. A few losers won't cause XBI to crash. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. Toggle navigationNovavax Inc. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. $0. 6% of the fund. FBT has a higher 5-year return than XBI (-0. ETF Channel Staff - Friday, October 20, 6:48 AM. $72. 03 per $1,000 of principal). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. And, again, it is in the top 15 holdings by weighting of the. Like IBB, XBI uses diversification to. The Direxion Daily Cloud Computing Bull 2X Shares seek daily investment results, before fees and expenses, of 200% of the performance of the Indxx USA Cloud Computing Index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Performance and Risk The ETF has lost about -29. Visitors trend 2W 10W 9M. 64 per share, with $174. XBI has traded between $62. Price Chart. 12% in the. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. BBC vs XBI. Feel free to the browse the list and view the comparisons that are of an interest to you. 50(-0. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Jun 23, 2022 10:49AM EDT. Dividend Yield. 67. TipRanks | Stock Market Research, News and Analyst Forecasts. Advertisement. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. 01%). Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 81 and $134. So far this year, XBI has lost about -5. Rather than analyzing the holdings of all ETFs and deciding which allocation is best it is easier to pick two that encompass large caps FBIOX or IBB and small/mid caps with equal weighting like the XBI. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. $5. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Direxion Daily FTSE China Bull 3X Shares ETF holdings by MarketWatch. The sale of ETFs is subject to an activity assessment fee (from $0. Assets Under Management. 19%. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. The fund has a beta of 0. IBB has 8. Across the 192 current stocks in the fund, all holdings have a weighting between 0. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 51 on Tuesday. Market Capitalization. 19%. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. Oct 10, 2022 01:14PM EDT. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. With XBI trading at a recent price near $131. . 50 down to $98. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. Themes & Subsectors ETFs. Fund Analysis. While IBB has many more holdings than XBI (376 vs. 13%) Gold 1,980. AMGN. XBI has traded between. The ETF return is roughly 4. It can be found in the fund’s most recent prospectus. XBI has a beta of 1. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 94 per share, with $121. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. Trades. com) ReturnsXBI's top 10 holdings account for about 10. XBI ETF’s holdings offer significant diversification. Minafi categorizes both of these funds as large funds. by Sweta Killa Published on September 18,2023. 32% of the total portfolio assets. XBI, whose index recently expanded, also owns only a handful of established biotech companies. It has a total of 153 holdings. ETF Channel Staff - Friday, October 20, 6:48 AM. 2013. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. As of 09/30/2023. 06 as the 52 week high point — that compares with a last trade of $112. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. 88%. VHT has a lower expense ratio than XBI (0. 33% so far, and is up roughly 4. 10 as of November 2, 2022. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Top 10 Holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 81. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. 15 billion.